Cooper Companies (COO) Total Non-Current Liabilities (2010 - 2026)
Cooper Companies (COO) recorded quarterly Total Non-Current Liabilities of $4.0 billion in Q2 2026, down 1.92% quarter-over-quarter from $4.1 billion in Q1 2026, and up 3.26% year-on-year from $3.9 billion in Q2 2025.
Cooper Companies (COO) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Cooper Companies has disclosed Total Non-Current Liabilities across 12 years of filings, most recently posting $4.0 billion for Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities rose 3.26% year-over-year to $4.0 billion; the trailing twelve-month figure through Apr 2026 stood at $4.0 billion (up 3.26% YoY), and the FY2025 full-year result was $3.9 billion, down 1.2% from the prior year.
- Total Non-Current Liabilities was $4.0 billion for Q2 2026 at Cooper Companies, down from $4.1 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $4.6 billion in Q2 2022 and troughed at $3.8 billion in Q3 2025.
- The 5-year median for Total Non-Current Liabilities is $4.0 billion (2025), against an average of $4.1 billion.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities soared 66.18% in 2022, then fell 12.23% in 2023.
- Year by year, Total Non-Current Liabilities stood at $4.1 billion in 2022, then fell by 1.83% to $4.0 billion in 2023, then decreased by 2.43% to $3.9 billion in 2024, then retreated by 1.2% to $3.9 billion in 2025, then grew by 2.68% to $4.0 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $4.0 billion in Q2 2026, $4.1 billion in Q1 2026, and $3.9 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 2.44 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 3.98 Bn |
| Jan 31, 2026 | 4.05 Bn |
| Oct 31, 2025 | 3.87 Bn |
| Jul 31, 2025 | 3.76 Bn |
| Apr 30, 2025 | 3.85 Bn |
| Jan 31, 2025 | 4.04 Bn |
| Oct 31, 2024 | 3.92 Bn |
| Jul 31, 2024 | 3.91 Bn |
| Apr 30, 2024 | 3.97 Bn |
| Jan 31, 2024 | 4.25 Bn |
| Oct 31, 2023 | 4.02 Bn |
| Jul 31, 2023 | 4.08 Bn |
| Apr 30, 2023 | 4.07 Bn |
| Jan 31, 2023 | 4.11 Bn |
| Oct 31, 2022 | 4.09 Bn |
| Jul 31, 2022 | 4.35 Bn |
| Apr 30, 2022 | 4.64 Bn |
| Jan 31, 2022 | 4.60 Bn |
| Oct 31, 2021 | 2.52 Bn |
| Jul 31, 2021 | 2.69 Bn |